Press release
Investigation announced for Long-Term Investors in shares of Heron Therapeutics, Inc. (NASDAQ: HRTX)
An investigation on behalf of current long term investors in Heron Therapeutics, Inc. (NASDAQ: HRTX) shares.
Investors who are current long term investors in Heron Therapeutics, Inc. (NASDAQ: HRTX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: HRTX stocks follows a lawsuit filed against Heron Therapeutics, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: HRTX stocks, concerns whether certain Heron Therapeutics, Inc. directors are liable in connection with the allegations made in that lawsuit.
The plaintiff alleges that the Defendants made false and/or misleading statements and/or failed to disclose that Heron had failed to include adequate Chemistry, Manufacturing, and Controls (“CMC”) and non-clinical information in its NDA for HTX-011, that the foregoing increased the likelihood that the FDA would not approve Heron’s NDA for HTX-011, and that as a result, Heron’s public statements were materially false and misleading at all relevant times.
Those who purchased shares of Heron Therapeutics, Inc. (NASDAQ: HRTX) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Heron Therapeutics, Inc. (NASDAQ: HRTX) here
News-ID: 1853738 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Heron
Heron Building Co Launches Exceptional Fence Building Services in Franklin and N …
Franklin, TN - July 1, 2024 - Heron Building Co, a leading name in the fence contracting industry, proudly announces the launch of its premier fence-building services [%20https://heronbuildingco.com/fence-company-in-franklin] across Franklin, Brentwood, Green Hills, College Grove, and Nashville, Tennessee. With over a decade of expertise, Heron Building Co specializes in crafting high-quality fences that combine functionality, security, and aesthetic appeal.
Image: https://www.getnews.info/uploads/3b3b34e7bc27c346583529f1750585af.jpg
Located at #1206 2000 Mallory Ln Suite 290 in Franklin, Heron…
Heron Corporation Acquires Assets from Flush Self-Pierce Riveting Business
Heron Intelligent Equipment [https://www.heron-welder.com/] Co. Ltd, a leading provider of metal joining equipment, has acquired the business assets of flush self-pierce riveting specialist AKH Inc. with main facilities in Danville, Indiana. The partial asset purchase offers Heron exclusive rights to sell the AKH fas-ner and an opportunity to serve a fast-growing assembly market in North America, with state-of-the art riveting technology.
AKH is a pioneer and market leader in flush self-piercing…
Bunion (Hallux Valgus) Market to Witness Upsurge in Growth During the Forecast P …
DelveInsight's "Bunion Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Bunion, historical and forecasted epidemiology as well as the Bunion market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Bunion market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Bunion Market Forecast
https://www.delveinsight.com/sample-request/bunion-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Bunion…
Aprepitant Market Analysis and Global Regional Outlook 2023-2030 | Merck & Co., …
Extensive analysis of the report "Aprepitant Market" is conducted by following key product positioning and monitoring the top competitors within the market framework by Infinitybusinessinsights.com. The report will assist reader with better understanding and decision making.
The Aprepitant market, closely linked to the pharmaceutical industry, encompasses the production and distribution of Aprepitant-based medications. Aprepitant, recognized for its effectiveness in managing chemotherapy-induced nausea and vomiting, finds application in cancer treatment and related…
Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market 2022 - Heron Ther …
Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market research analysis and data lend a hand to businesses for the planning of production, product launches, costing, inventory, purchasing, and marketing strategies. The company profiles of all the chief and dominating market players and brands who are taking steps such as product launches, joint ventures, mergers, and acquisitions are mentioned in the report. The Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market…
Aprepitant Market 2027: Industry Growth, Competitive Analysis & Future Prospects …
This report properly guides new entrants as well as established players to make a difference in the global Aprepitant market. It is just the right resource for any player looking to plan new strategies.
LOS ANGELES, United States: The report is an all-inclusive research study of the global Aprepitant market taking into account the growth factors, recent trends, developments, opportunities, and competitive landscape. The market analysts and researchers have done extensive…
